Delta Investment Management, LLC Soligenix, Inc. Transaction History

Delta Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$0.66 - $1.1 $18,928 - $31,548	-28,680 Reduced 59.7%	19,359 $13,000
Q2 2021 Aug 06, 2021	BUY	$0.87 - $1.58 $4,350 - $7,900	5,000 Added 11.62%	48,039 $53,000
Q1 2021 May 14, 2021	BUY	$1.31 - $2.35 $960 - $1,722	733 Added 1.73%	43,039 $66,000
Q4 2020 Feb 04, 2021	BUY	$1.26 - $2.75 $3,150 - $6,875	2,500 Added 6.28%	42,306 $54,000
Q3 2020 Nov 12, 2020	BUY	$1.7 - $2.61 $25,500 - $39,150	15,000 Added 60.47%	39,806 $71,000
Q3 2019 Nov 05, 2019	BUY	$0.72 - $1.31 $7,200 - $13,100	10,000 Added 67.54%	24,806 $23,000
Q2 2019 Aug 08, 2019	BUY	$0.67 - $0.91 $9,920 - $13,473	14,806 New	14,806 $10,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $125M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Delta Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Delta Investment Management, LLC with notifications on news.